Cargando…

Identification of an Individualized Prognostic Biomarker for Serous Ovarian Cancer: A Qualitative Model

Serous ovarian cancer is the most common type of ovarian epithelial cancer and usually has a poor prognosis. The objective of this study was to construct an individualized prognostic model for predicting overall survival in serous ovarian cancer. Based on the relative expression orderings (Ea > E...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Fengyuan, Li, Na, Zhang, Qi, Ma, Liyuan, Li, Xinqiao, Hu, Tao, Zhong, Haijian, Li, Hongdong, Hong, Guini
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777083/ https://www.ncbi.nlm.nih.gov/pubmed/36553135 http://dx.doi.org/10.3390/diagnostics12123128

Ejemplares similares

Construct of qualitative diagnostic biomarkers specific for glioma by pairing serum microRNAs
por: Li, Hongdong, et al.
Publicado: (2023)

Predict ovarian cancer by pairing serum miRNAs: Construct of single sample classifiers
por: Hong, Guini, et al.
Publicado: (2022)

Screening prognostic markers for hepatocellular carcinoma based on pyroptosis-related lncRNA pairs
por: Wu, Tong, et al.
Publicado: (2023)

Tissue Biomarkers in Prognostication of Serous Ovarian Cancer following Neoadjuvant Chemotherapy
por: Khandakar, Binny, et al.
Publicado: (2014)

Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer
por: Győrffy, Balázs
Publicado: (2023)

Identification of Prognosis Biomarkers for High-Grade Serous Ovarian Cancer Based on Stemness
por: Wang, Zhihang, et al.
Publicado: (2022)

An individualized prognostic signature for gastric cancer patients treated with 5-Fluorouracil-based chemotherapy and distinct multi-omics characteristics of prognostic groups
por: Li, Xiangyu, et al.
Publicado: (2016)

Screening and Identification of Biomarkers in Ascites Related to Intrinsic Chemoresistance of Serous Epithelial Ovarian Cancers
por: Huang, He, et al.
Publicado: (2012)

SIRT4 and SIRT6 Serve as Novel Prognostic Biomarkers With Competitive Functions in Serous Ovarian Cancer
por: Wang, Huihuan, et al.
Publicado: (2021)

Identification of Potential Prognostic Competing Triplets in High-Grade Serous Ovarian Cancer
por: Zhao, Jian, et al.
Publicado: (2021)

Identification of clinical and molecular features of recurrent serous borderline ovarian tumour
por: Lu, Ziyang, et al.
Publicado: (2022)

External validation suggests Integrin beta 3 as prognostic biomarker in serous ovarian adenocarcinomas
por: Partheen, Karolina, et al.
Publicado: (2009)

Increased Expression of Holliday Junction-Recognizing Protein (HJURP) as an Independent Prognostic Biomarker in Advanced-Stage Serous Ovarian Carcinoma
por: Li, Lin, et al.
Publicado: (2018)

Identification of a 3-mRNA signature as a novel potential prognostic biomarker in patients with ovarian serous cystadenocarcinoma in G2 and G3
por: Zhou, Jiahua, et al.
Publicado: (2019)

Identifying Reproducible Molecular Biomarkers for Gastric Cancer Metastasis with the Aid of Recurrence Information
por: Li, Mengyao, et al.
Publicado: (2016)

Genome-Wide Identification and Validation of Gene Expression Biomarkers in the Diagnosis of Ovarian Serous Cystadenocarcinoma
por: Zalfa, Francesca, et al.
Publicado: (2022)

TCR Clonality and Genomic Instability Signatures as Prognostic Biomarkers in High Grade Serous Ovarian Cancer
por: Lecuelle, Julie, et al.
Publicado: (2021)

AKR1B1 as a Prognostic Biomarker of High-Grade Serous Ovarian Cancer
por: Hojnik, Marko, et al.
Publicado: (2022)

KRT19 is a Promising Prognostic Biomarker and Associates with Immune Infiltrates in Serous Ovarian Cystadenocarcinoma
por: Sun, Zhe, et al.
Publicado: (2023)

BDP1 as a biomarker in serous ovarian cancer
por: Cabarcas‐Petroski, Stephanie, et al.
Publicado: (2022)

Bioinformatic Analysis for Influential Core Gene Identification and Prognostic Significance in Advanced Serous Ovarian Carcinoma
por: Song, Changho, et al.
Publicado: (2021)

Identification of a Novel Tumor Microenvironment Prognostic Signature for Advanced-Stage Serous Ovarian Cancer
por: Zheng, Mingjun, et al.
Publicado: (2021)

Similar Source of Differential Blood mRNAs in Lung Cancer and Pulmonary Inflammatory Diseases: Calls for Improved Strategy for Identifying Cancer-Specific Biomarkers
por: Hong, Guini, et al.
Publicado: (2014)

Identification of bromodomain-containing proteins prognostic value and expression significance based on a genomic landscape analysis of ovarian serous cystadenocarcinoma
por: Zhang, Juan, et al.
Publicado: (2022)

Identification of biomarkers complementary to homologous recombination deficiency for improving the clinical outcome of ovarian serous cystadenocarcinoma
por: Shi, Zhiwen, et al.
Publicado: (2021)

AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer
por: Ardizzoia, Alessandra, et al.
Publicado: (2023)

Assessment of Significant Pathway Signaling and Prognostic Value of GNG11 in Ovarian Serous Cystadenocarcinoma
por: Jiang, Ming-Min, et al.
Publicado: (2021)

Prognostic relevance of acquired uniparental disomy in serous ovarian cancer
por: Tuna, Musaffe, et al.
Publicado: (2015)

Biological and prognostic value of ETV5 in high-grade serous ovarian cancer
por: Zhang, Lu, et al.
Publicado: (2021)

Identification of molecular alterations in leukocytes from gene expression profiles of peripheral whole blood of Alzheimer’s disease
por: Li, Hongdong, et al.
Publicado: (2017)

Importance of Potential New Biomarkers in Patient with Serouse Ovarian Cancer
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2021)

A five-DNA methylation signature act as a novel prognostic biomarker in patients with ovarian serous cystadenocarcinoma
por: Guo, Wenna, et al.
Publicado: (2018)

Deep Learning Provides a New Magnetic Resonance Imaging-Based Prognostic Biomarker for Recurrence Prediction in High-Grade Serous Ovarian Cancer
por: Liu, Lili, et al.
Publicado: (2023)

Identifying disease-associated pathways in one-phenotype data based on reversal gene expression orderings
por: Hong, Guini, et al.
Publicado: (2017)

Development of a novel transcription factors-related prognostic signature for serous ovarian cancer
por: Li, He, et al.
Publicado: (2021)

WTAP is a prognostic marker of high-grade serous ovarian cancer and regulates the progression of ovarian cancer cells
por: Yu, Hai-Lan, et al.
Publicado: (2019)

Identification of metastasis and prognosis-associated genes for serous ovarian cancer
por: Yang, Yijun, et al.
Publicado: (2020)

Prognostic role of CIP2A expression in serous ovarian cancer
por: Böckelman, C, et al.
Publicado: (2011)

Prognostic gene expression signature for high-grade serous ovarian cancer
por: Millstein, J., et al.
Publicado: (2020)

Identification of candidate genes associated with tubal origin of high-grade serous ovarian cancer
por: Xiang, Li, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4l559o2st88lbsaooplrafpe1f